APA

Hernández-Campos A., Velázquez-Martínez I., Castillo R., López-Vallejo F., Jia P., Yu Y., Giulianotti M. A. & Medina-Franco J. L. (20110103). Docking of protein kinase B inhibitors: implications in the structure-based optimization of a novel scaffold. : Chemical biology & drug design.

Chicago

Hernández-Campos Alicia, Velázquez-Martínez Israel, Castillo Rafael, López-Vallejo Fabian, Jia Ping, Yu Yongping, Giulianotti Marc A and Medina-Franco Jose L. 20110103. Docking of protein kinase B inhibitors: implications in the structure-based optimization of a novel scaffold. : Chemical biology & drug design.

Harvard

Hernández-Campos A., Velázquez-Martínez I., Castillo R., López-Vallejo F., Jia P., Yu Y., Giulianotti M. A. and Medina-Franco J. L. (20110103). Docking of protein kinase B inhibitors: implications in the structure-based optimization of a novel scaffold. : Chemical biology & drug design.

MLA

Hernández-Campos Alicia, Velázquez-Martínez Israel, Castillo Rafael, López-Vallejo Fabian, Jia Ping, Yu Yongping, Giulianotti Marc A and Medina-Franco Jose L. Docking of protein kinase B inhibitors: implications in the structure-based optimization of a novel scaffold. : Chemical biology & drug design. 20110103.